The synergy works because GLP-1 therapy addresses the neurochemical drivers of hunger, while intermittent fasting extends the metabolic window during which your body taps stored energy
Doing so sends signals of fullness or satiety so one does not feel the urge to eat excessively throughout the day
If you experience trouble breathing, swelling, or severe skin reactions after using it, seek immediate medical attention
Nimacimab, a monoclonal antibody (large molecule), is significantly more brain-restricted7, with no psychiatric adverse events observed in our preclinical studies7 or Phase 1 study7 in nonalcoholic fatty liver disease (NAFLD) patients
Because the medicine is fragile in the stomach, the pill includes an absorption helper and must be taken correctly to work: on an empty stomach first thing in the morning, with no more than a few sips of plain water, followed by a wait before any food, drink, or other pills